Key statistics
On Thursday, Calliditas Therapeutics AB (LC8:MUN) closed at 18.17, -0.60% below its 52-week high of 18.28, set on Jun 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.17 |
---|---|
High | 18.17 |
Low | 18.17 |
Bid | 18.09 |
Offer | 18.26 |
Previous close | 18.17 |
Average volume | 7.78 |
---|---|
Shares outstanding | 59.94m |
Free float | 8.05m |
P/E (TTM) | -- |
Market cap | 12.36bn SEK |
EPS (TTM) | -8.95 SEK |
Data delayed at least 15 minutes, as of Sep 19 2024 07:10 BST.
More ▼
Press releases
- Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
- Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)
- Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
- Calliditas Interim Report January to June 2024
- Invitation to the presentation of Calliditas´s interim report January - June 2024
- Number of shares and votes in Calliditas Therapeutics
- Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy
- Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis
- Launch of Phase 3 clinical trial with Nefecon in Japan
More ▼